I read what you are saying, but you are telling me not to

New Post Public Reply Private Reply Replies (1) Message Board
hylander Zolis_onkel #16898
312
I read what you are saying, but you are telling me not to comment with the same statements, but all I am seeing are the same statements days, weeks, months literally.

Joe is doing this, or Joe is doing that or not to worry because this is going to happen.

The problem is, we really don't know. We hear this or we hear that, then everything changes. Then we do not hear a word.

Then we 'assume' this is going to happen. You do know what the word assume usually means to you and me?

NGIO has been moved again and again and everyone is making excuses with no validity, only wishes about funding that may or may not materialize. I hope it does materialize, I really do.

But, right now, we only know the history of what was stated, what has been done and what has not been done. I go by facts and by history.

What I am currently seeing overall is CCs and PRs that have stated plainly one thing and showing something different with no follow-up to explain exactly why.

Again, we can assume all we want, but it doesn't change what's going on and the fact we could very well be here in 6 more months continuing to assume the very same things.

We were told the Form 10 was needed then the S1. It's as simple as that. Nothing else. We can assume anything. Joe wants the funding to push everything through the roof, Joe wants NGIO to look spectacular, who knows. But nothing was said, other than the SEC needed the Form 10 put in and approved first, then the S1, which the S1 was going in right after the Dividend mind you.

I think it was you who put out the 120 days for BARDA now. So, in fact, Generex might not know for a good bit if they get the funding or not. If they are waiting months more to file the S1 until they hear from BARDA, then is NGIO not as stable as anyone thinks or is Generex not capable of doing more than one thing at once?

I hope that all of this works out for the sake of everyone involved. The Generex / NGIO teams and the shareholders. I just hope that Generex management does not drag their feet to long and everyone suffers because of it.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 3

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
SIAL West Asia Ignites Global F&B Trade at Guangzhou

Updated Category News Views 3

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 2

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
VEVOR's Labor Day Salute to Home DIY Warriors

Updated Category News Views 1

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Continue Reading
Consumer365 Lauds Happy Head's Custom Hair Treatments

Updated Category News Views 6

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 1

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Unlocking Insights: South Chicagoland Home Inspections

Updated Category News Views 0

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 2

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading

Top 5 Most Recently Viewed Articles

Celsius Holdings Faces Legal Challenges—What Investors Should Know

Updated Category News Views 365

Understanding the Recent Class Action Lawsuit Against Celsius Holdings Recently, Celsius Holdings, Inc. (NASDAQ: CELH) has found itself at the center of a significant legal challenge. This class action lawsuit, filed by a prominent law firm, seeks to address serious allegations involving the company's financial disclosures and dealings with PepsiCo, Inc. The Accusations...

Continue Reading
Five Star Bancorp Announces Next Cash Dividend for Shareholders

Updated Category News Views 138

Five Star Bancorp's Dividend Announcement Five Star Bancorp (Nasdaq: FSBC) is pleased to share exciting news regarding its latest shareholder return strategy. The company has declared a cash dividend amounting to $0.20 per share on its voting common stock. This marks a continuing commitment to delivering value to its shareholders and is a pivotal part of the firm’s...

Continue Reading
Enovix Shares Decline as Q3 Report Shifts Market Sentiment

Updated Category News Views 151

Enovix Experiences Stock Decline Post Q3 Report Enovix Corporation (NASDAQ: ENVX) is facing a significant drop in its stock price as investors react to its recent third-quarter financial results. The company reported quarterly losses and provided guidance for the upcoming quarter that did not meet market expectations, leading to a decline in share value. Details of the...

Continue Reading
Borregaard ASA Launches Strategic Share Repurchase Program

Updated Category News Views 129

Borregaard ASA Announces Share Repurchase Initiative Borregaard ASA, known by the ticker OSE: BRG, is set to execute a strategic share repurchase program aiming to enhance shareholder value. This initiative involves the buyback of up to 200,000 shares of the company’s outstanding common stock. Purpose of the Share Repurchase Program The primary goal of this repurchase...

Continue Reading
Forian Expands Influence with Acquisition of Kyber Data Science

Updated Category News Views 103

Forian's Strategic Move to Acquire Kyber Data Science Forian Inc. (Nasdaq: FORA), a prominent data science company, is making headlines with its recent acquisition of Kyber Data Science LLC. This move is set to enhance Forian's capabilities in the healthcare analytics arena while also enabling the company to expand into the financial services sector. Kyber Data Science: A...

Continue Reading